GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Status:
Recruiting
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the
GORE® CARDIOFORM Septal Occluder for migraine headache relief